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114a Sunday, March 6, 2011transition from the active state to the intermediate state. In the absence of cal-
cium the rapid decrease in fluorescence was followed by a slower fluorescence
increase as the inactive state became populated. Acrylodan labeled smooth
muscle tropomyosin behaved much like labeled skeletal muscle tropomyosin
(Borrego-Diaz & Chalovich, 2010). When the same experiment was done
with acrylodan labeled tropomyosin-actin-caldesmon a similar pattern of fluo-
rescence decrease and increase occurred. The rapid decrease corresponded to
movement to the intermediate state and could not be distinguished from the
rate of S1-ATP detachment. The slower redevelopment of fluorescence differed
from the case with troponin in that it occurred as caldesmon binding increased
to occupy sites vacated by S1. Changes in caldesmon binding were monitored
by NBD probes on caldesmon. We sometimes observed an increase in acrylo-
dan fluorescence when caldesmon was mixed with acrylodan-tropomyosin
alone. Thus in the case of caldesmon, S1-ATP detachment occurs with a rapid
fluorescence decrease that was independent of caldesmon. The slow fluores-
cence redevelopment occurred as caldesmon bound to actin-tropomyosin. We
have not determined if in that case the fluorescence change coincided with
tropomyosin movement.
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Cardiac Troponin T: A Sarcomeric AKAP, Tethers Protein Kinase a at the
Myofilaments
Amelia Sumandea, Mary Garcia-Cazarin, Catherine Bozio, Gail Sievert,
C. William Balke, Marius P. Sumandea.
Efficient and specific phosphorylation of PKA substrates, elicited in response to
beta-adrenergic stimulation, require spatially confined pools of PKA anchored
in proximity of its substrates. PKA-dependent phosphorylation of cardiac sar-
comeric proteins has been the subject of intense investigations. Yet, the iden-
tity, composition, and function of PKA complexes at the sarcomeres have
remained elusive. Here we report the identification and characterization of
a novel sarcomeric AKAP (A kinase anchoring protein), cardiac troponin T
(cTnT). Using the yeast two-hybrid technology in screening two adult human
heart cDNA libraries, we identified the regulatory subunit of PKA as interacting
with human cTnT bait. Immunoprecipitation studies show that cTnT is a dual
specificity AKAP, interacting with both PKA-regulatory subunits type I and II.
The disruptor peptide Ht31, but not Ht31P (control), abolished cTnT/PKA-R
association. Truncations and point mutations identified an amphipathic helix
domain in cTnT as the PKA binding site. This was confirmed by a peptide
SPOT assay in the presence of Ht31 or Ht31P (control). Gelsolin-dependent re-
moval of thin filament proteins also reduced myofilament-bound PKA-type II.
Using a cardiac troponin (cTn) exchange procedure that substitutes the endog-
enous cTn complex with a recombinant cTn complex we show PKA-type II is
troponin-bound in the myofilament lattice. Displacement of PKA-cTnT com-
plexes correlates with a significant decrease in myofibrillar PKA activity.
Taken together, our data propose a novel role for cTnT as a dual-specificity sar-
comeric AKAP.
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Effect of Hypertrophic Cardiomyopathy Mutations on Protein-Protein
Interactions in the Thin Filament
Shannamar Dewey, Qian Xu, Susan Nguyen, Aldrin V. Gomes.
Familial hypertrophic cardiomyopathy (FHC) refers to a heterogeneous group
of cardiac diseases linked to over 630 mutations in sarcomeric proteins. Anal-
ysis of the phenotype of the associated disease, the disease outcome, and the
functional consequences of FHC mutations all indicate a complex process of
pathogenesis that cannot be predicted solely by the localization of the mutation.
However, mutations linked to HCM patients tend to increase the calcium sen-
sitivity of contraction in skinned fiber and myosin ATPase experiments. Muta-
tions linked to dilated cardiomyopathy (DCM), however, are commonly
associated with a decrease in calcium sensitivity of contraction. These general-
izations do not hold true for all FHC mutations. The process of myocardial con-
traction and relaxation also depends on complex protein-protein interactions
within the sarcomeric unit. Altered myocardial contractility resulting from dis-
turbed interaction profiles of sarcomeric proteins may play a critical role in the
pathogenesis of FHC. A few studies that have investigated protein-protein in-
teractions involving one protein with a cardiomyopathy-linked mutation show
distinct disturbances associated with HCM as compared to DCM. In this study,
we investigated the effects of several FHC linked mutations, including well-in-
vestigated mutations such as cardiac troponin T (cTnT) I79N, R278C and
F110I using a mammalian two-hybrid system. The interaction between cTnT
and alpha-tropomyosin (Tm) was significantly higher for the cTnT F110I
than wild-type cTnT. A DCM mutation has previously been shown to increase
the affinity of cTnT for Tm. cTnT I79N and R278C mutants show similar
affinity for Tm as wild-type cTnT. These results suggest that some FHC and
DCM mutations may show similar changes in cTnT-Tm interactions whileother mutations may not affect cTnT-Tm interactions. This work is partly sup-
ported by NIH grant HL096819.
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Jingsheng Liang, Michael J. Ackerman, James D. Potter.
Mutations in TNNC1 are still considered uncommon causes of hypertrophic
cardiomyopathy (HCM) and linkage studies are not always available to deter-
mine inheritance. Here we report a clinical and functional characterization of
a novel TNNC1 mutation identified in a pediatric HCM patient. The proband
hosting the TNNC1 mutation was clinically evaluated including medical his-
tory, physical examination, 12-lead electrocardiogram, chest X-ray and genetic
testing. The disease presented with multiple episodes of ventricular fibrillation
and aborted sudden cardiac death. The patient demonstrated a substantial de-
gree of hypertrophy with QT prolongation. Genetic testing indicated that the
mutation was a de novo occurrence. Functional studies were performed as an-
other useful tool in establishing causation of disease. cTnC-extracted cardiac
skinned fibers were reconstituted with the cTnC-HCM mutation and increased
the Ca2þ sensitivity with no effect on the maximal force. In addition, reconsti-
tuted actomyosin ATPase assays showed that the Ca2þ sensitivity was similar
in the presence of 100% mutant cardiac Troponin C (cTnC) or 50% mutant:
50% WT cTnC. The effect of the mutation on actomyosin ATPase activation
and inhibition is currently being investigated. The Ca2þ affinity of the cTnC
mutant was evaluated by fluorescence. At all levels; troponin complex, thin fil-
ament (TF) and TF þ myosin subfragment 1 (to a lesser degree) the Ca2þ af-
finity was increased. These results suggest that this mutation has a direct affect
on the Ca2þ sensitivity of the myofilament which may alter Ca2þ handling and
contribute to the arrhythmogenesis seen in the patient. In summary, mutations
in TNNC1 may predispose to the pathogenesis of a fatal arrhythmogenic sub-
type of HCM. The underlying functional alterations of the myofilament con-
taining the mutant cTnC may further contribute to the severity of the clinical
phenotype.
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Effect of Hypertrophic Cardiomyopathy Linked Troponin C Mutations
and Troponin I Phosphorylation on the Rate of Calcium Dissociation
from the Thin Filament
Acchia Albury, Nicholas Swindle, Darl R. Swartz, Svetlana Tikunova.
The objective of this work was to investigate the effect of hypertrophic cardio-
myopathy linked A8V, E134D and D145E mutations on the rate of calcium dis-
sociation from cardiac troponin C (cTn)C on the thin filament under different
phosphorylation states of cTnI. While the E134D mutation did not affect the
rate of calcium dissociation, the A8V and D145E mutations led to significantly
slower rates of calcium dissociation from cTnC on the thin filament. The effect
of A8V, E134D and D145E mutations on the rate of calcium dissociation from
the thin filament was also examined after cTnI was replaced by either PKA
(S22D/S23DcTnI) or PKC (S41D/S43DcTnI) phosphorylation mimetic of
cTnI. Replacement of cTnI by either the PKA or PKC phosphorylation mimetic
of cTnI dramatically accelerated calcium dissociation from wild-type cTnC on
the thin filament. The A8V mutation still led to significantly slower rate of cal-
cium dissociation from cTnC on the thin filament after cTnI was replaced by
the PKA phosphorylation mimetic of cTnI. However, in the presence of PKC
phosphorylation mimetic of cTnI, the ability of A8V mutation to slow the
rate of calcium dissociation from the cTnC on thin filament was abolished.
The E134D mutation exerted minor to no effect on the rate of calcium dissoci-
ation from cTnC on the thin filament regardless of cTnI phosphorylation status.
On the other hand, the D145E mutation led to significantly slower rates of cal-
cium dissociation from cTnC on the thin filament after cTnI was replaced by
either PKA or PKC phosphorylation mimetic of cTnI. Thus, the ability of hy-
pertrophic cardiomyopathy linked cTnC mutations to affect the rate of calcium
dissociation from cTnC on the thin filament varies depending on phosphoryla-
tion status of cTnI.
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Jose Renato Pinto, Shi Wei Yang, Marc-Phillip Hitz, Michelle S. Parvatiyar,
Michelle A. Jones, Jingsheng Liang, Victor Kokta, Michelle Jaeggi,
Gregor Andelfinger, James D. Potter.
A novel double deletion in cardiac troponin T (cTnT) of two highly conserved
amino acids (N100 and E101) was found in a restrictive cardiomyopathic
(RCM) pediatric patient. Clinical evaluation revealed the presence of left atrial
